Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  GM-K562 cell vaccine
Find trials that include:  Any drugs shown
Results 1-2 of 2 for your search:
Start Over
Recombinant Interferon Alpha-2a and Sargramostim or Vaccine Therapy in Treating Patients with Chronic Phase Chronic Myelogenous Leukemia Receiving Tyrosine Kinase Inhibitor Therapy
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: J05121, NCI-2011-00392, CDR0000492005, JHOC-J05121, NA_00001887, NCT00363649
Vaccine Therapy in Treating Patients with Previously Treated Follicular Lymphoma
Status: Temporarily closed
Phase: Phase I
Type: Treatment
Age: 40 and over
Trial IDs: 06-275, NCI-2010-00094, NCT00487305
Start Over